BIT.AX - Biotron Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures

Market cap (intra-day) 564.58M
Enterprise value 349.02M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)
Price/book (mrq)6.57
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6-13.93

Trading information

Stock price history

Beta (5Y monthly) -1.68
52-week change 337.31%
S&P500 52-week change 310.93%
52-week high 30.1850
52-week low 30.0500
50-day moving average 30.0955
200-day moving average 30.0853

Share statistics

Avg vol (3-month) 35.31M
Avg vol (10-day) 33.35M
Shares outstanding 5701.93M
Float 513.02M
% held by insiders 115.43%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 327 Mar 2006

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2019
Most-recent quarter (mrq)31 Dec 2019

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-27.72%
Return on equity (ttm)-45.21%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)1.07M
EBITDA -3.52M
Net income avi to common (ttm)-3.42M
Diluted EPS (ttm)-0.0060
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.67M
Total cash per share (mrq)0.01
Total debt (mrq)60.82k
Total debt/equity (mrq)0.72
Current ratio (mrq)22.92
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-3.36M
Levered free cash flow (ttm)-2.17M